通过调节大鼠肠道微生物群,SCM-198可改善肺动脉高血压

Jianyu Xiong1, Qinyang Ge1, Bohan Fu1

  • 1Laboratory of Drug Discovery from Natural Resources and Industrialization and Faculty of Chinese Medicine, Macau University of Science and Technology, Macau, China.

Journal of thoracic disease
|December 11, 2025
PubMed
概括

SCM-198 (Leonurine) 通过改善肠道微生物群和调节血管通路,有效治疗肺动脉高血压 (PAH). 这项研究强调SCM-198作为一种潜在的PAH辅助疗法.